Keyphrases
Pediatric Patients
100%
Aerococcus Urinae
100%
Mycotic Aneurysm
100%
Infective Endocarditis
100%
Neuroprotection
100%
Magnesium
100%
Placebo Groups
100%
Magnesium Sulfate
100%
Acute Stroke
100%
Symptom Onset
50%
Modified Rankin Scale
50%
Neuroprotective Agents
50%
Drug Infusion
50%
Stroke Symptoms
50%
Disability Outcome
50%
High-score
50%
Rare Cause
33%
Elderly Patients
33%
Urinary Tract Infection
33%
Mantel-Haenszel Test
25%
Paramedic
25%
Neuroprotective
25%
Patient Arrivals
25%
Placebo
25%
Serious Adverse Events
25%
Loading Dose
25%
Stroke Onset
25%
Acceptable Safety
25%
Cerebral Ischemia
25%
Stroke Severity
25%
Delayed Initiation
25%
Phase II Trial
25%
Between-group Difference
25%
Disability
25%
Disability Status
25%
Motor Scale
25%
Severity Ranges
25%
Magnesium Sulfate Therapy
25%
Intravenous Magnesium Sulfate
25%
Motor Deficits
25%
Intracranial Hemorrhage
25%
Suspected Stroke
25%
Final Diagnosis
25%
Safety Profile
25%
Medicine and Dentistry
Aerococcus
100%
Pediatrics Patient
100%
Infective Endocarditis
100%
Mycotic Aneurysm
100%
Neuroprotection
100%
Magnesium Sulfate
100%
Apoplexy
100%
Placebo
62%
Magnesium
50%
Neuroprotective Agent
37%
Elderly Patient
33%
Urinary Tract Infection
33%
Modified Rankin Scale
25%
Drug Infusion
25%
Adverse Event
12%
Cerebral Hemorrhage
12%
Infusion
12%
Mantel Haenszel Test
12%
Loading Drug Dose
12%
Brain Ischemia
12%
Final Diagnosis
12%
Pharmacology, Toxicology and Pharmaceutical Science
Magnesium Sulfate
100%
Cerebrovascular Accident
100%
Neuroprotection
100%
Placebo
62%
Neuroprotective Agent
37%
Rankin Scale
25%
Brain Hemorrhage
12%
Adverse Event
12%
Brain Ischemia
12%